Bettina Bannert Selected Research

Bettina Bannert Research Topics

3	Rheumatoid Arthritis 08/2022 - 01/2017
2	Rheumatic Diseases (Rheumatism) 01/2019 - 01/2018
1	Gout 01/2022
1	Inflammation (Inflammations) 01/2022
1	Arthritis (Polyarthritis) 01/2022
1	Giant Cell Arteritis (Horton Disease) 01/2022
1	Axial Spondyloarthritis 01/2019
1	Back Pain (Backache) 01/2019
1	Diphtheria 01/2019
1	Human Influenza (Influenza) 01/2019
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2019
1	Ankylosing Spondylitis 01/2019
1	Tetanus 01/2019
1	Systemic Scleroderma (Systemic Sclerosis) 03/2013
1	Weight Loss (Weight Reduction) 01/2011

2	AutoantibodiesIBA 01/2019 - 03/2013
1	Abatacept (Orencia)FDA Link 08/2022
1	tocilizumab (atlizumab)FDA Link 01/2022
1	ChemokinesIBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Chemotactic FactorsIBA 01/2022
1	Cysteine Proteases (Cysteine Protease)IBA 01/2019
1	O,O-diisopropyl-S-benzylthiophosphate (IBP)IBA 01/2019
1	cathepsin SIBA 01/2019
1	Rituximab (Mabthera)FDA Link 01/2019
1	AntigensIBA 01/2019
1	Bromodeoxyuridine (BrdU)IBA 01/2019
1	Immunoglobulin A (IgA)IBA 01/2019
1	Immunoglobulin G (IgG)IBA 01/2019
1	Tetanus Toxoid (Vaccine, Tetanus)FDA Link 01/2019
1	HLA-B27 Antigen (HLA B27 Antigen)IBA 01/2019
1	Diphtheria-Tetanus VaccineIBA 01/2019
1	petesicatibIBA 01/2019
1	Retinaldehyde (Retinal)IBA 01/2018
1	tofacitinibIBA 01/2017
1	Janus Kinase InhibitorsIBA 01/2017
1	AntibodiesIBA 03/2013

1	Therapeutics 01/2011